Chris Zeal  Criou um novo artigo
8 C

JARDIANCE for CKD: A Turning Point in Nephrology? | # healthcare #empagliflozin #jardiance #chronic Kidney Disease

JARDIANCE for CKD: A Turning Point in Nephrology?

JARDIANCE for CKD: A Turning Point in Nephrology?

JARDIANCE (empagliflozin), a sodium-glucose co-transporter-2 (SGLT2) inhibitor, has shown significant promise in improving outcomes for CKD patients.